Preparation of Recombinant  -Thrombin: High-Level Expression of Recombinant Human Prethrombin-2 and Its Activation by Recombinant Ecarin

  • Yonemura Hiroshi
    Applied Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Imamura Takayuki
    First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Soejima Kenji
    First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Nakahara Yo
    Applied Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Morikawa Wataru
    Applied Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Ushio Yoshitaka
    Applied Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Kamachi Yasuharu
    Applied Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Nakatake Hiroshi
    First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Sugawara Keishin
    Applied Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Nakagaki Tomohiro
    First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
  • Nozaki Chikateru
    First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)

書誌事項

タイトル別名
  • Preparation of Recombinant α-Thrombin: High-Level Expression of Recombinant Human Prethrombin-2 and Its Activation by Recombinant Ecarin
  • Preparation of Recombinant アルファ Thrombin High Level Expression of Recombinant Human Prethrombin 2 and Its Activation by Recombinant Ecarin
  • Preparation of recombinant alpha-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin

この論文をさがす

抄録

We have established a large-scale manufacturing system to produce recombinant human α-thrombin. In this system, a high yield of α-thrombin is prepared from prethrombin-2 activated by recombinant ecarin. We produced human prethrombin-2 using mouse myeloma cells and an expression plasmid carrying the chicken β-actin promoter and mutant dihydrofolate reductase gene for gene amplification. To increase prethrombin-2 expression further, we performed fed-batch cultivation with the addition of vegetable peptone in 50 liters of suspension culture. After five feedings of vegetable peptone, the expression level of the recombinant prethrombin-2 reached 200 μg/ml. Subsequently, the recombinant prethrombin-2 could be activated to α-thrombin by recombinant ecarin expressed in a similar manner. Finally, recombinant α-thrombin was purified to homogeneity by affinity chromatography using a benzamidine-Sepharose gel. The yield from prethrombin-2 in culture medium was approximately 70%. The activity of the purified recombinant α-thrombin, including hydrolysis of a chromogenic substrate, release of fibrinopeptide A, and activation of protein C, was indistinguishable from that of plasma-derived α-thrombin. Our system is suitable for the large-scale production of recombinant α-thrombin, which can be used in place of clinically available α-thrombin derived from human or bovine plasma.

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (34)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ